ScienceDex / Researcher record
Landi, Daniel Bryce
- Duke University · Neurosurgery (NIH department code)
From the FY2021 NIH awards this investigator leads as contact PI. The department is the award's.
- R01 Holder
- Early Career
NIH Funding · FY2021
Award data coverage
One fiscal year is available for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2021): $697.1K in linked award amounts across 1 award record · Award-linked rank #14987.
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2021 · selected1 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2021 onlyCareer claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2021 award categories
- Neurosurgery
FY2021 award records by amount
NIH award records listing Landi, Daniel Bryce as a PI. Multi-PI records show the full award amount for context.
- 1R01FD007283-01R01Contact PIPhase 2 trial of a novel peptide vaccine targeting CMV antigen for newly diagnosed pediatric high grade glioma and diffuse intrinsic pontine glioma and recurrent medulloblastomaDuke University · Neurosurgery (NIH department code)$697.1Kaward amount
Award organization
Organizations that administered FY2021 awards listing Landi, Daniel Bryce as a PI.
FY2021 award administered by Duke University (NC).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2021First NIH AwardDuke University
- 2021$500K Cumulative Funding